Published in Psychopharmacology (Berl) on July 12, 2013
Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res (1970) 4.65
Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science (1976) 4.07
Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl (1971) 3.53
A randomized controlled trial of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced tardive dyskinesia. J Clin Psychiatry (2010) 2.07
Psychosis pathways converge via D2high dopamine receptors. Synapse (2006) 1.78
The role of serotonin receptors in the action of atypical antipsychotic drugs. Curr Opin Pharmacol (2011) 1.38
Memory processes governing amphetamine-induced psychomotor sensitization. Neuropsychopharmacology (2002) 1.36
Dopamine D2 receptors as treatment targets in schizophrenia. Clin Schizophr Relat Psychoses (2010) 1.29
Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. Science (1977) 1.24
Treatment of substance abusing patients with comorbid psychiatric disorders. Addict Behav (2011) 1.22
The presynaptic component of the serotonergic system is required for clozapine's efficacy. Neuropsychopharmacology (2010) 1.09
Sudden darkness induces a high activity-low anxiety state in male and female rats. Physiol Behav (1998) 1.02
Cocaine conditioning and cocaine sensitization: what is the relationship? Behav Brain Res (1998) 0.93
Behavioral sensitization to apomorphine in pigeons (Columba livia): blockade by the D1 dopamine antagonist SCH-23390. Behav Neurosci (2004) 0.85
Opposite effects of low versus high dose haloperidol treatments on spontaneous and apomorphine induced motor behavior: evidence that at a very low dose haloperidol acts as an indirect dopamine agonist. Behav Brain Res (2012) 0.84
Improvement of tardive dyskinesia and dystonia associated with aripiprazole following a switch to quetiapine: case report and review of the literature. J Clin Pharm Ther (2011) 0.84
Apomorphine sensitization: evoking conditions, context dependence, effect persistence and conditioned nature. Behav Pharmacol (2002) 0.83
Prior haloperidol, but not olanzapine, exposure augments the pursuit of reward cues: implications for substance abuse in schizophrenia. Schizophr Bull (2012) 0.81
Apomorphine-induced context-specific behavioural sensitization is prevented by the D1 antagonist SCH-23390 but potentiated and uncoupled from contextual cues by the D2 antagonist sulpiride. Psychopharmacology (Berl) (2010) 0.79
Low dose apomorphine induces context-specific sensitization of hypolocomotion without conditioning: support for a new state dependent retrieval hypothesis of drug conditioning and sensitization. Pharmacol Biochem Behav (2009) 0.79
Reversal of apomorphine locomotor sensitization by a single post-conditioning trial treatment with a low autoreceptor dose of apomorphine: a memory re-consolidation approach. Pharmacol Biochem Behav (2011) 0.78
Dopamine binding following prolonged haloperidol pretreatment. Ann Neurol (1978) 0.78
Behavioral sensitization to dopaminergic inhibitory and stimulatory effects induced by low vs. high dose apomorphine treatments: an unconventional dose and response reversal sensitization challenge test reveals sensitization mechanisms. Behav Brain Res (2009) 0.78
Memory re-consolidation and drug conditioning: an apomorphine conditioned locomotor stimulant response can be enhanced or reversed by a single high versus low apomorphine post-trial treatment. Psychopharmacology (Berl) (2011) 0.78
Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity. Biol Psychiatry (1982) 0.78
Apomorphine conditioning and sensitization: the paired/unpaired treatment order as a new major determinant of drug conditioned and sensitization effects. Pharmacol Biochem Behav (2010) 0.77
Conditioning and experiential factors affecting the development of sensitization to apomorphine. Behav Neurosci (1989) 0.77
Post-trial apomorphine at an autoreceptor dose level can eliminate apomorphine conditioning and sensitization: support for the critical role of dopamine in re-consolidation. Behav Brain Res (2012) 0.77
Residual dopamine receptor desensitization following either high- or low-dose sub-chronic prior exposure to the atypical anti-psychotic drug olanzapine. Psychopharmacology (Berl) (2012) 0.76
Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors. Prog Neurobiol (2007) 1.26
Treatment of addiction and anxiety using extinction approaches: neural mechanisms and their treatment implications. Pharmacol Biochem Behav (2010) 0.96
Opposite effects of low versus high dose haloperidol treatments on spontaneous and apomorphine induced motor behavior: evidence that at a very low dose haloperidol acts as an indirect dopamine agonist. Behav Brain Res (2012) 0.84
Baclofen inhibits opiate-induced conditioned place preference and associated induction of Fos in cortical and limbic regions. Brain Res (2003) 0.82
Serotonin as an important mediator of cocaine's behavioral effects. Drugs Today (Barc) (2003) 0.80
Conditioned locomotion induced by unilateral intrastriatal administration of apomorphine: D(2) receptor activation is critical but not the expression of the unconditioned response. Brain Res (2006) 0.80
Cocaine increases serotonergic activity in the hippocampus and nucleus accumbens in vivo: 5-HT1a-receptor antagonism blocks behavioral but potentiates serotonergic activation. Synapse (2002) 0.79
The selective serotonin(1A)-receptor antagonist WAY 100635 blocks behavioral stimulating effects of cocaine but not ventral striatal dopamine increase. Behav Brain Res (2002) 0.79
Apomorphine-induced context-specific behavioural sensitization is prevented by the D1 antagonist SCH-23390 but potentiated and uncoupled from contextual cues by the D2 antagonist sulpiride. Psychopharmacology (Berl) (2010) 0.79
Low dose apomorphine induces context-specific sensitization of hypolocomotion without conditioning: support for a new state dependent retrieval hypothesis of drug conditioning and sensitization. Pharmacol Biochem Behav (2009) 0.79
Reversal of apomorphine locomotor sensitization by a single post-conditioning trial treatment with a low autoreceptor dose of apomorphine: a memory re-consolidation approach. Pharmacol Biochem Behav (2011) 0.78
Behavioral sensitization to dopaminergic inhibitory and stimulatory effects induced by low vs. high dose apomorphine treatments: an unconventional dose and response reversal sensitization challenge test reveals sensitization mechanisms. Behav Brain Res (2009) 0.78
Memory re-consolidation and drug conditioning: an apomorphine conditioned locomotor stimulant response can be enhanced or reversed by a single high versus low apomorphine post-trial treatment. Psychopharmacology (Berl) (2011) 0.78
Apomorphine conditioning and sensitization: the paired/unpaired treatment order as a new major determinant of drug conditioned and sensitization effects. Pharmacol Biochem Behav (2010) 0.77
The effects of cocaine on light-induced activity. Brain Res Bull (2011) 0.77
Serotonin1A-receptor antagonism blocks psychostimulant properties of diethylpropion in marmosets (Callithrix penicillata). Eur J Pharmacol (2005) 0.77
Intracellular 5-HT 2C-receptor dephosphorylation: a new target for treating drug addiction. Trends Pharmacol Sci (2006) 0.77
Post-trial apomorphine at an autoreceptor dose level can eliminate apomorphine conditioning and sensitization: support for the critical role of dopamine in re-consolidation. Behav Brain Res (2012) 0.77
Hippocampus 5-HT(1A)-receptors attenuate cocaine-induced hyperlocomotion and the increase in hippocampal but not nucleus accumbens 5-HT. Hippocampus (2004) 0.76
Residual dopamine receptor desensitization following either high- or low-dose sub-chronic prior exposure to the atypical anti-psychotic drug olanzapine. Psychopharmacology (Berl) (2012) 0.76
7-OH-DPAT effects on latent inhibition: low dose facilitation but high dose blockade: implications for dopamine receptor involvement in attentional processes. Pharmacol Biochem Behav (2007) 0.76
Behavioral sensitization produced by a single administration of apomorphine: implications for the role of Pavlovian conditioning in the mediation of context-specific sensitization. Pharmacol Biochem Behav (2007) 0.75
Apomorphine locomotor sensitization can be potentiated by environmental change: evidence for a non-Pavlovian associative behavioral contrast factor in sensitization expression. Behav Brain Res (2011) 0.75
Anxiolytic-like effects of the selective 5-HT1A receptor antagonist WAY 100635 in non-human primates. Eur J Pharmacol (2003) 0.75
The expression of locomotor sensitization to apomorphine is dependent on time interval between injection and testing. Pharmacol Biochem Behav (2008) 0.75